You're reading the free version. Trader adds the live tape and alerts.
Start tracking
TVTX Sale Disclosure
Rote William E. · SEC Form 4 · Filed Sep 17, 2026
Sale
Calculated transaction value
$4.11M
Rote William E. Chief Research Officer
TVTX
Travere Therapeutics
TVTX
Transaction date
Sep 16, 2026
Public filing date
Sep 17, 2026
Filing lag
Filed 1 day later
TVTX daily price context
Close on/before transaction
$63.48
Sep 16, 2026
First close after public filing
$62.76
Sep 18, 2026
30-day return after filing
-19.55%
Through Oct 19, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 65,104 shares @ $63.12
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001698262-26-000005
Filing cohort
Transactions in this filing
Showing 15 of 16
Trades
16
Issuers
1
Estimated value
$17.23M
Buys / sales
0 / 6
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Travere Therapeutics, Inc. TVTX | Exercise | Sep 16, 2026 | $0 |
| Travere Therapeutics, Inc. TVTX | Sale | Sep 16, 2026 | $3.04M |
| Travere Therapeutics, Inc. TVTX | Exercise | Sep 16, 2026 | $850.3K |
| Travere Therapeutics, Inc. TVTX | Exercise | Sep 16, 2026 | $0 |
| Travere Therapeutics, Inc. TVTX Current | Sale | Sep 16, 2026 | $4.11M |
| Travere Therapeutics, Inc. TVTX | Exercise | Sep 16, 2026 | $6.29K |
| Travere Therapeutics, Inc. TVTX | Exercise | Sep 16, 2026 | $1.55M |
| Travere Therapeutics, Inc. TVTX | Exercise | Sep 16, 2026 | $0 |
| Travere Therapeutics, Inc. TVTX | Exercise | Sep 15, 2026 | $0 |
| Travere Therapeutics, Inc. TVTX | Exercise | Sep 15, 2026 | $0 |
| Travere Therapeutics, Inc. TVTX | Exercise | Sep 15, 2026 | $984.75K |
| Travere Therapeutics, Inc. TVTX | Exercise | Sep 15, 2026 | $712.11K |
| Travere Therapeutics, Inc. TVTX | Sale | Sep 15, 2026 | $3.96M |
| Travere Therapeutics, Inc. TVTX | Sale | Sep 15, 2026 | $1.82M |
| Travere Therapeutics, Inc. TVTX | Sale | Sep 15, 2026 | $190.95K |